Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Ozturk, C. [1 ]
Sahin, U. [2 ]
Seval, G. C. [1 ]
Bozdag, S. C. [1 ]
Toprak, S. K. [1 ]
Yuksel, M. K. [1 ]
Topcuoglu, P. [1 ]
Ozcan, M. [1 ]
Gurman, G. [1 ]
Ilhan, O. [1 ]
Arslan, O. [1 ]
机构：
[1] Ankara Univ, Ankara, Turkey
[2] Medicana Int Ankara Hosp, Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P432
引用
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [1] Efficacy of Venetoclax Combination Therapy with Hypomethylating Agents in Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
    Mittal, Varun
    Lo, Mimi
    Damon, Lloyd E.
    Gaensler, Karin L.
    Martin, Thomas G., III
    Olin, Rebecca L.
    Smith, Catherine C.
    Logan, Aaron C.
    BLOOD, 2019, 134
  • [2] Venetoclax and Hypomethylating Agents Followed By Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
    Rautenberg, Christina
    Ragette, Anja
    Kaivers, Jennifer
    Neuendorff, Nina
    Hanoun, Maher
    Reinhardt, Hans Christian
    Schroeder, Thomas
    BLOOD, 2022, 140 : 12943 - 12944
  • [3] VENETOCLAX AND HYPOMETHYLATING AGENTS FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Rautenberg, Christina
    Stelljes, Matthias
    Acker, Fabian
    Holtick, Udo
    Jost, Edgar
    Schliemann, Christoph
    Ragette, Anja
    Kaivers, Jennifer
    Neuendorff, Nina
    Hanoun, Maher
    Schmalbrock, Laura K.
    Braitsch, Krishan
    Verbeek, Mareike
    Goetze, Katharina
    Bug, Gesine
    Reinhardt, Christian
    Kroeger, Nicolaus
    Schroeder, Thomas
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 163 - 163
  • [4] Venetoclax, Hypomethylating Agents and Dli for Salvage Treatment of Myeloid Malignancies Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
    Schuler, Esther
    Wagner-Drouet, Eva-Maria
    Ajib, Salem
    Bug, Gesine
    Crysandt, Martina
    Dressler, Sabine
    Hausmann, Andreas
    Heidenreich, Daniela
    Hirschbuehl, Klaus
    Hoepting, Matthias
    Jost, Edgar
    Kaivers, Jennifer
    Klein, Stefan
    Kordelas, Lambros
    Kriege, Oliver
    Mueller, Lutz
    Rautenberg, Christina
    Schaffrath, Judith
    Schmid, Christoph
    Wolff, Daniel
    Haas, Rainer
    Bornhaeuser, Martin
    Schroeder, Thomas
    Kobbe, Guido
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 590 - 591
  • [5] Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Azenkot, Tali
    Gaut, Daria
    Wieduwilt, Matthew J.
    Oliai, Caspian
    Jonas, Brian A.
    Mittal, Varun
    Logan, Aaron C.
    Muffly, Lori S.
    Mannis, Gabriel N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E191 - E194
  • [6] Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
    Im, Annie
    Raptis, Anastasios
    Hou, Jing-Zhou
    Tompkins, Cheryl
    Loucks, Melissa
    Guay, Mary
    Phillips, Julie
    Boyiadzis, Michael
    Agha, Mounzer
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S293 - S293
  • [7] Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant
    Ionescu, Filip
    David, Jerel C.
    Ravichandran, Apoorva
    Sallman, David A.
    Sweet, Kendra
    Komrokji, Rami S.
    Chan, Onyee
    Kuykendall, Andrew
    Padron, Eric
    Faramand, Rawan
    Bejanyan, Nelli
    Khimani, Farhad
    Elmariah, Hany
    Pidala, Joseph
    Mishra, Asmita
    Perez, Lia
    Nishihori, Taiga
    Lancet, Jeffrey E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (06): : 400 - 406
  • [8] Hypomethylating Agents and Low-Dose Venetoclax for Relapse Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
    Vigil, Carlos Enrique
    Silverman, Margarida
    Carter, Thomas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S104 - S104
  • [9] Hypomethylating Agents in Combination with Venetoclax As a Bridge to Allogeneic Transplant in Acute Myeloid Leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Gaut, Daria
    Mittal, Varun
    Oliai, Caspian
    Muffly, Lori S.
    Logan, Aaron C.
    Mannis, Gabriel N.
    BLOOD, 2020, 136
  • [10] Safety and Efficacy of Venetoclax Combined with Hypomethylating Agents or Low-Dose Cytarabine for Acute Myeloid Leukemia before and after Allogeneic Hematopoietic Cell Transplantation
    Pessoa Mendes, Rafael Fernandes
    Fatobene, Giancarlo
    Molla, Vinicius
    Helman, Ricardo
    Rodrigues, Morgani
    Schmidt Filho, Jayr
    Novis, Yana
    Rodrigues, Celso Arrais
    Rocha, Vanderson
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S300 - S300
12345